Document Detail


Inflammatory changes parallel the early stages of Alzheimer disease.
MedLine Citation:
PMID:  17052803     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Alzheimer disease (AD) is the most prominent cause of dementia in the elderly. To determine changes in the AD brain that may mediate the transition into dementia, the gene expression of approximately 10,000 full-length genes was compared in mild/moderate dementia cases to non-demented controls that exhibited high AD pathology. Including this latter group distinguishes this work from previous studies in that it allows analysis of early cognitive loss. Compared to non-demented high-pathology controls, the hippocampus of AD cases with mild/moderate dementia had increased gene expression of the inflammatory molecule major histocompatibility complex (MHC) II, as assessed with microarray analysis. MHC II protein levels were also increased and inversely correlated with cognitive ability. Interestingly, the mild/moderate AD dementia cases also exhibited decreased number of T cells in the hippocampus and the cortex compared to controls. In conclusion, transition into AD dementia correlates with increased MHC II(+) microglia-mediated immunity and is paradoxically paralleled by a decrease in T cell number, suggesting immune dysfunction.
Authors:
A Parachikova; M G Agadjanyan; D H Cribbs; M Blurton-Jones; V Perreau; J Rogers; T G Beach; C W Cotman
Related Documents :
17908053 - Pharmacogenetic aspects of therapy with cholinesterase inhibitors: the role of cyp2d6 i...
20467093 - Interleukins (il-7 and il-7r) gene expression and thymoquinones role in the amelioratio...
20211023 - Prodigal: prokaryotic gene recognition and translation initiation site identification.
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't     Date:  2006-10-18
Journal Detail:
Title:  Neurobiology of aging     Volume:  28     ISSN:  1558-1497     ISO Abbreviation:  Neurobiol. Aging     Publication Date:  2007 Dec 
Date Detail:
Created Date:  2007-10-23     Completed Date:  2007-11-20     Revised Date:  2013-06-07    
Medline Journal Info:
Nlm Unique ID:  8100437     Medline TA:  Neurobiol Aging     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1821-33     Citation Subset:  IM    
Affiliation:
Institute for Brain Aging & Dementia, University of California, 1113 Gillespie Neuroscience Research Facility, Irvine, CA 92697-4540, USA. aparachi@uci.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Aged, 80 and over
Alzheimer Disease / immunology*
Brain / immunology*
Cytokines / immunology*
Dementia / immunology*
Encephalitis / immunology*
Female
Gene Expression Regulation / immunology
Humans
Grant Support
ID/Acronym/Agency:
AG 020241/AG/NIA NIH HHS; AG 023173/AG/NIA NIH HHS; AG00538/AG/NIA NIH HHS; AG16573/AG/NIA NIH HHS; NS 050895/NS/NINDS NIH HHS; P01 AG000538-229001/AG/NIA NIH HHS; P30 AG19610/AG/NIA NIH HHS
Chemical
Reg. No./Substance:
0/Cytokines
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Phosphorylation of methyl-CpG binding protein 2 (MeCP2) regulates the intracellular localization dur...
Next Document:  PPAR-gamma Pro12Ala genotype and risk of cognitive decline in elders.